Treatment of musculoskeletal pain and associated anxiety with an ethoheptazine-aspirin-meprobamate combination (equagesic): a controlled study.
D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D000704:Analysis of Variance; D001007:Anxiety / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use*; D001381:Azepines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008161:Lumbosacral Region; D008297:Male; D008620:Meprobamate / Q000627:therapeutic use*; D008875:Middle Aged; D009135:Muscular Diseases / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D013035:Spasm / Q000188:drug therapy; D013180:Sprains and Strains / Q000188:drug therapy
D000700:Analgesics; D001381:Azepines; D004338:Drug Combinations; C007609:aspirin, meprobamate drug combination; D008620:Meprobamate; D001241:Aspirin